The Market for Mass Spectrometry in Clinical Testing Applications

Jan 3, 2017
208 Pages - Pub ID: KLI15217025
Share this report
 
Online Download $4,500
Departmental Site License (one location, 10 users) $6,750
Global Site License $9,000
The Market for Mass Spectrometry in Clinical Testing Applications

Mass spectrometry has been primarily used in research applications, with early applications focused on small molecules. However, development of soft-ionization techniques such as matrix-assisted laser desorption ionization (MALDI) and electrospray ionization (ESI) has made it possible to study larger molecules such as proteins, peptides, DNA, and other large molecules without extensive fragmentation, opening up a whole new world of opportunities as mass spectrometry now moves into the clinical laboratory. The Market for Mass Spectrometry in Clinical Testing Applications focuses on the worldwide market for mass spectrometry products – instruments and consumables – and includes the following information:
  • Mass Spectrometry Market, Worldwide, 2016 and 2021 [Products and Services Provided by Mass Spectrometry Companies] (Total mass spectrometry market; Product Revenue: Instruments, Reagents/Consumables, Total product revenue; Service revenue)
  • Mass Spectrometry Market (Products) – Research vs. Clinical, 2016 and 2021
  • Mass Spectrometry Product Market by Geographical Region, Worldwide, 2016 and 2021 (North America, Europe, Asia, Rest of World, Total Market)
  • Mass Spectrometry Market Share by Company, 2016 (%)
  • Clinical Mass Spectrometry Product Market by Intended Clinical Category, 2016 (%) (Microbial Identification, Small molecule applications)
  • Mass Spectrometry Market – By Type of Mass Spectrometer (%)
The report looks as well at the market drivers and challenges for mass spectrometry in the clinical lab, including the advantages and disadvantages of mass spectrometry and current trends in the mass spectrometry market.

The clinical diagnostic applications of mass spectrometry are expanding. Mass spectrometry has already had a disruptive impact on microbial identification. Mass spectrometry is now being applied to a growing number of oncology applications, and there is a growing awareness of the importance of both genomic and proteomic information for many oncology diagnostic applications. Mass spectrometry has the potential to be applied to other diagnostic applications as well, as discussed in this report.

With this market potential, many companies are making deals in this promising area. The report discusses selected investment and financing agreements in mass spectrometry companies, selected acquisitions, selected agreements between mass spectrometry companies, selected agreements between mass spectrometry platform/reagent companies and mass spectrometry software companies, selected company agreements between mass spectrometry companies and diagnostic companies or clinical laboratories, selected agreements among mass spectrometry companies and pharmaceutical or biopharmaceutical companies (includes contract research organizations providing services to pharma companies), and selected mass spectrometry company agreements with academic or other non-profit organizations.

The report includes company profiles of the players in the mass spectrometry market:
  • 908 Devices Inc.
  • Abbott Laboratories
  • Advion, Inc.
  • Agena Bioscience, Inc.
  • Agilent Technologies Inc.
  • Andromas SAS
  • Applied Proteomics, Inc.
  • Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
  • BGI
  • Biocrates Life Sciences AG
  • Biodesix, Inc.
  • Biognosys AG
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Caprion Biosciences, Inc.
  • caprotec bioanalytics GmbH
  • Danaher Corporation
  • Fluidigm Corporation
  • ImaBiotech
  • Integrated Diagnostics, Inc.
  • JEOL Ltd.
  • KineMed, Inc.
  • Microsaic Systems plc
  • mosaiques diagnostics and therapeutics AG and DiaPat GmbH
  • PerkinElmer, Inc.
  • Proteome Sciences plc
  • SCIEX
  • Sera Prognostics, Inc.
  • Shimadzu Corporation
  • Thermo Fisher Scientific, Inc.
  • Waters Corporation
Chapter 1: Executive Summary
Overview
Scope and Methodology
Market Overview
Future Prospects in the Mass Spectrometry Market
Chapter 2: Introduction
Brief History of Mass Spectrometry
Point-of-View
Chapter 3: Mass Spectrometry Overview
Types of Mass Spectrometry – Overview
Companies Marketing Mass Spectrometry Platforms and Related Products
Mass Spectrometry Platforms in the Clinical Laboratory
Chapter 4: Mass Spectrometry in Research and the Clinical Laboratory
Research Applications of Mass Spectrometry
Mass Spectrometry in the Clinical Laboratory
Early Applications of Mass Spectrometry in the Clinical Laboratory
Oncology
Infectious Disease
Other Clinical Applications of Mass Spectrometry
Other Applications of Mass Spectrometry
Chapter 5: Deals – Mass Spectrometry Companies
Investments and Financing Agreements
Mergers and Acquisitions
Other Corporate Agreements and Collaborations
Collaborations/Agreements Between Two Mass Spectrometry Companies
Collaborations/Agreements with Diagnostic Companies and/or Clinical Laboratories
Collaborations/Agreements with Pharmaceutical and Biopharmaceutical Companies
Other Company Collaborations/Agreements
Collaborations and Other Agreements with Universities, Non-Profit Research Institutes and Government
Chapter 6: Mass Spectrometry in the Clinical Laboratory – Market Drivers and Challenges
Mass Spectrometry Technology and Platforms
Need for Integration of Pre-analytical, Analytical, and Post-analytical Components of Mass Spectrometry Based Assays; Advances in Mass Spectrometry Platforms
Mass Spectrometry vs. Immunoassays – Advantages and Disadvantages
Mass Spectrometry Clinical Market Drivers
Increasing Number of Clinical Applications for Mass Spectrometry
Oncology Market Drivers
Newborn Screening and Genetic Analysis Market Drivers
Infectious Disease Market Drivers
Market Drivers for Other Segments of the Clinical Mass Spectrometry Market
Competition
Potential Impact of Mass Spectrometry on Other Markets
Most Mass Spectrometry Clinical Assays Today are Laboratory Developed Tests (LDTs)
Regulation of Mass Spectrometry-Based In Vitro Diagnostic (IVD) Tests
Future Prospects
Chapter 7: Mass Spectrometry Market Analysis
Mass Spectrometry Market Overview
Research versus Clinical Mass Spectrometry Market
Mass Spectrometry Market – Geographical Distribution
Mass Spectrometry Market – Market Shares by Company
Mass Spectrometry Market (Products Sold to Clinical Laboratories) – By Intended Clinical Category, 2016
Mass Spectrometry Market – By Type of Mass Spectrometer
Chapter 8: Company Profiles – Mass Spectrometry Companies
908 Devices Inc.
Abbott Laboratories
Recent Revenue History
Company Overview – With a Focus on Sequencing
Advion, Inc.
Agena Bioscience, Inc.
Applying MassARRAY System to Clinical Diagnostics
Agilent Technologies Inc.
Recent Revenue History
Company Overview
Andromas SAS
Applied Proteomics, Inc.
Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
Revenue History
Company Overview
BGI
Biocrates Life Sciences AG
Biodesix, Inc.
Biodesix Lung Reflex™
Research Activities
Investors/Financings
Other Agreements
Biognosys AG
bioMérieux SA
Recent Revenue History
Company Overview
Traditional Microbiology
Mass Spectrometry for Clinical Laboratories
Bio-Rad Laboratories, Inc.
Recent Revenue History
Company Overview
Bruker Corporation
Recent Revenue History
Company Overview
Caprion Biosciences, Inc.
caprotec bioanalytics GmbH
Danaher Corporation
Recent Revenue History
Company Overview
Fluidigm Corporation
Recent Revenue History
Company Overview
ImaBiotech
Integrated Diagnostics, Inc.
Financing History
Selected Deals
Indi Molecular
JEOL Ltd.
Recent Revenue History
Company Overview
KineMed, Inc.
Microsaic Systems plc
Recent Revenue History
Company Overview
mosaiques diagnostics and therapeutics AG and DiaPat GmbH
PerkinElmer, Inc.
Recent Revenue History
Company Overview
Proteome Sciences plc
Recent Revenue History
Company Overview
SCIEX
Sera Prognostics, Inc.
Shimadzu Corporation
Recent Revenue History
Company Overview
Thermo Fisher Scientific, Inc.
Recent Revenue History
Company Overview
Waters Corporation
Recent Revenue History
Company Overview
List of Exhibits
1: Executive Summary
Table 1-1: Worldwide Mass Spectrometry Product Revenues (Instruments and
Consumables), 2016 and 2021
3: Mass Spectrometry Overview
Table 3-1: Selected Companies Developing/Marketing Mass Spectrometers
Table 3-2: Selected Companies Marketing Tools/Reagents/Kits/Consumables
for Mass Spectrometry
Table 3-3: Selected Companies Marketing Software for Mass Spectrometry
Table 3-4: Selected Companies Marketing Mass Spectrometers and/or Assays for the
Clinical Laboratory [CE-Marked and/or 510(k) cleared]
4: Mass Spectrometry in Research and the Clinical Laboratory
Table 4-1: Selected Mass Spectrometry Based Oncology Tests
Table 4-2: Selected Mass Spectrometry Based Infectious Disease Tests for
Microorganism Identification and Antibiotic Susceptibility
Table 4-3: Selected Other Mass Spectrometry Based Clinical Tests
5: Deals – Mass Spectrometry Companies
Table 5-1: Selected Investment and Financing Agreements in Mass Spectrometry
Companies
Table 5-2: Selected Acquisitions of Mass Spectrometry Companies
Table 5-3: Selected Company Agreements Between Two Mass Spectrometry
Companies
Table 5-4: Selected Company Agreements Between Mass Spectrometry Platform/
Reagent Companies and Mass Spectrometry Software Companies
Table 5-5: Selected Company Agreements Between Mass Spectrometry Companies
and Diagnostic Companies or Clinical Laboratory
Table 5-6: Selected Agreements Mass Spectrometry Companies and Pharmaceutical
or Biopharmaceutical Companies [Includes Contract Research Organizations
Providing Services to Pharma Companies]
Table 5-7: Selected Other Mass Spectrometry Company Agreements
Table 5-8: Selected Mass Spectrometry Company Agreements with Academic or
Other Non-Profit Organizations
6: Mass Spectrometry in the Clinical Laboratory – Market Drivers and
Challenges
Table 6-1: Advantages and Disadvantages of Mass Spectrometry
Table 6-2: Trends in the Mass Spectrometry Market
7: Mass Spectrometry Market Analysis
Table 7-1: Mass Spectrometry Market, Worldwide, 2016 and 2021 [Products and
Services Provided by Mass Spectrometry Companies] (Total mass spectrometry
market; Product Revenue: Instruments, Reagents/Consumables, Total product
revenue; Service revenue)
Table 7-2: Mass Spectrometry Market (Products) – Research vs. Clinical, 2016
and 2021
Table 7-3: Mass Spectrometry Product Market by Geographical Region, Worldwide,
2016 and 2021 (North America, Europe, Asia, Rest of World, Total Market)
Table 7-4: Mass Spectrometry Market Share by Company, 2016 (%)
Table 7-5: Clinical Mass Spectrometry Product Market by Intended Clinical
Category, 2016 (%) (Microbial Identification, Small molecule applications)
Table 7-6: Mass Spectrometry Market – By Type of Mass Spectrometer (%)
8: Company Profiles – Mass Spectrometry Companies
Table 8-1: Abbott Revenues (2013, 2014, 2015, 3 quarters of 2016)
Table 8-2: Agilent Technologies Revenues (2013, 2014, 2015)
Table 8-3: bioMérieux Revenues (2013, 2014, 2015, 3 quarters of 2016)
Table 8-4: Bio-Rad Laboratories Revenues (2013, 2014, 2015, 3 quarters of
2016)
Table 8-5: Bruker Corporation Revenues (2013, 2014, 2015, 3 quarters of 2016)
Table 8-6: Danaher Revenues (2013, 2014, 2015, 3 quarters of 2016)
Table 8-7: Fluidigm Revenues (2013, 2014, 2015, 3 quarters of 2016)
Table 8-8: Microsaic Systems Revenues (2013, 2014, 2015)
Table 8-9: PerkinElmer Revenues (2015 and 2016)
Table 8-10: Proteome Sciences Revenues (2013, 2014, 2015)
Table 8-11: Shimadzu Revenues (Years Ending March 31, 2016 and 2015)
Table 8-12: Thermo Fisher Scientific Revenues (2013, 2014, 2015)
Table 8-13: Waters Corporation Revenues (2013, 2014, 2015)

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.